ArticleFrontiers in pharmacology2025

Nobiletin mitigates benign prostatic hyperplasia by suppressing prostate cell proliferation through regulation of cell cycle progression, signaling pathways, transcription factor activity, and the androgen-signaling axis.

Jun-Hui Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.